Physician profile
Solomon Blake Spiegel
NPI 1871852293
$4,369.91
in general payments reported to CMS, 2019-2025
36 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $472 · 2021: $551 · 2022: $802 · 2023: $618 · 2024: $969 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $614.18 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $599.90 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $330.45 | 2021-2025 | |
| Cvrx, INC. | $254.32 | 2024-2025 | Barostim Neo System |
| Endologix LLC | $188.46 | 2024 | Torus Stent Graft System, Endocross Device |
| Philips North America LLC | $174.95 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $169.70 | 2019-2025 | Onpattro, Amvuttra |
| Astrazeneca Pharmaceuticals LP | $156.63 | 2019-2025 | Farxiga |
| Medtronic, INC. | $150.85 | 2021-2025 | Abre, Avalus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.41 | 2021-2025 | Jardiance |
| Abbott Laboratories | $142.97 | 2021-2023 | Amplatzer Amulet |
| Pfizer INC. | $139.16 | 2022-2025 | |
| Abiomed | $125.33 | 2022-2023 | Impella |
| Sanofi-Aventis U.S. LLC | $120.13 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $93.95 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $89.88 | 2019-2020 | |
| Depuy Synthes Sales INC. | $89.77 | 2022 | |
| Atricure, INC. | $88.30 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.04 | 2022-2024 | Lifevest |
| Irhythm Technologies, INC. | $77.33 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Potrero Medical, INC. | $60.51 | 2021-2022 | |
| Baxter Healthcare | $56.14 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $55.45 | 2020-2024 | Repatha |
| Biotronik INC. | $46.90 | 2020-2025 | Biomonitor |
| Boston Scientific Corporation | $40.55 | 2019-2021 | |
| Astellas Pharma US INC | $39.24 | 2020-2021 | |
| Edwards Lifesciences Corporation | $36.38 | 2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $31.72 | 2022-2023 | Camzyos |
| Chiesi USA, INC. | $27.12 | 2025 | Kengreal, Cleviprex |
| Lantheus Medical Imaging, INC. | $26.14 | 2025 | |
| Heartflow, INC. | $22.00 | 2023 | Ffrct |
| Cardinal Health 200 LLC | $21.87 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $19.18 | 2023 | Inpefa |
| Kls-Martin L.P. | $15.29 | 2024 | |
| Intact Vascular, INC. | $14.43 | 2019 | |
| Medicomp INC | $13.28 | 2023 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Spiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.